Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 1/20 | 0.34 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | RORC | P51449 | 4/20 | 0.32 |
| ▸ | ACP1 | P24666 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710267 | 0.90 | RXFP1 (0.34) | RORC | |
| SCHEMBL6708653 | 0.90 | RORC (0.36) | LMNARORC | |
| SCHEMBL6710089 | 0.87 | NTRK1 (0.33) | NTRK1PARP14LMNARORCACP1 | |
| SCHEMBL6830370 | 0.86 | LMNA (0.36) | NTRK1PARP14LMNARORCACP1 | |
| SCHEMBL6707936 | 0.84 | LMNA (0.35) | PARP14LMNARORC | |
| SCHEMBL6707965 | 0.82 | NTRK1 (0.35) | NTRK1ACP1 | |
| SCHEMBL6709946 | 0.81 | LMNA (0.36) | PARP14LMNARORC | |
| SCHEMBL6707799 | 0.77 | RORC (0.35) | LMNARORCBRD4HDAC1 | |
| SCHEMBL6708003 | 0.77 | KMT2A (0.32) | PARP14RORCBRD4HDAC1 | |
| SCHEMBL6710172 | 0.77 | ROCK2 (0.35) | NTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | NTRK1 3519/4885PARP14 2597/4885LMNA 4062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.